Renal anemia and L-carnitine therapy in hemodialysis patients
Journal of Clinical Nutrition & Dietetics · 2015
DOI: 10.4172/2472-1921.100004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Nutrition & Dietetics, 2015. Verfasst von Hadi Tabibi.
Abstract (Originalsprache)
Tel: 00989122445367 Renal anemia is a common complication in hemodialysis (HD) patients, and resulting mainly from reduced erythropoietin production [1,2]. Renal anemia can result in reduced exercise tolerance, impaired cognition, depression, dyspnea, heart failure and increased mortality in HD patients [1,2]. Erythropoietin therapy is a standard treatment for renal anemia; however, 5–10% of HD patients show erythropoietin resistance [1,3].
Zitieren
APA
Tabibi, H. (2015). Renal anemia and L-carnitine therapy in hemodialysis patients. Journal of Clinical Nutrition & Dietetics. https://doi.org/10.4172/2472-1921.100004
Vancouver
Tabibi H. Renal anemia and L-carnitine therapy in hemodialysis patients. Journal of Clinical Nutrition & Dietetics. 2015. doi:10.4172/2472-1921.100004
BibTeX
@article{Tabibi2015,
author = {Tabibi, Hadi},
title = {Renal anemia and L-carnitine therapy in hemodialysis patients},
journal = {Journal of Clinical Nutrition & Dietetics},
year = {2015},
doi = {10.4172/2472-1921.100004}
}
EUVIMED